mClinica

mClinica is a Singapore-based social enterprise that operates across Southeast Asia. We develop mobile apps to strengthen pharmacy practice, connecting more than 100,000 pharmacy professionals who serve millions of patients each month and generate billions of data points, allowing us to deliver health solutions at an unprecedented speed and scale.

mClinica’s business model combines the best of the private sector - sustainability and innovation - with the heart of the public sector to maximize public health impact. We focus on pharmacies because they are the first point of access to modern medical advice and care for millions of people in Southeast Asia, especially the poor and rural. Pharmacists, uniquely, have a critical role in primary health care and are also of commercial interest to the private sector.

Our private sector clients often focus on priority disease areas like diabetes, cancer, and hypertension. Our public sector partners, in contrast, have worked to combat HIV, tuberculosis, and malaria. Combining the public and private sectors allows us give pharmacists free accredited education across disease areas through our SwipeRx app, reduce the price of medicines with our Connect app, and even assemble national health information systems through our SnapRx app.

mClinica is proud to be Southeast Asia's premier social enterprise. The shared value we derive from the public and private sectors strengthens not only our bottom line but our ability to transform healthcare starting from the smallest mom-and-pop pharmacy on up.

mClinica is backed by some of the world’s best known impact investors, including the Global Innovation Fund (whose LPs include USAID, UKAID, DFAT, and other development institutions), Patamar Capital, MDI Ventures, Endeavor Catalyst, Kickstart Ventures, Spiral Ventures, and 500 Startups.